Predictive Oncology Inc. announced the successful development of predictive models for 21 unique compounds sourced from the University of Michigan's Natural Products Discovery Core, marking a ...

The classical drug discovery paradigm begins with a known molecular target: a protein whose modulation is expected to reverse ...

Lumo leverages advanced machine learning to reduce calibration time, and flag low-confidence response factor predictions.

A research team has created an artificial intelligence model that could significantly improve the accuracy and reduce the time and cost of the drug development process. The new model, called CODE-AE, ...

Based on these initial screenings, the researchers then developed AI models which could comb through a large swath of the estimated 1 X 10 60 compounds (that's 1 followed by 60 zeroes) in the ...

A new generation of compounds is being studied for its potential to support brain plasticity and adaptive change, potentially reshaping how mental health conditions are treated.